China Oral Industry Group Holdings Limited announced the issuance of 273.42 million new ordinary shares on 2 April 2026 under its general mandate, expanding the company’s issued share capital by 19.99%.
Before the transaction, the dental‐care products maker had 1.37 billion shares outstanding. Post-issue, the total number of issued shares rose to 1.64 billion. The new shares, designated as consideration shares, were allotted at HKD 0.079 each in accordance with an agreement disclosed on 16 March 2026.
The filing confirms that the board duly authorised the transaction and that all regulatory, listing-rule and legal requirements have been met. No treasury shares were outstanding, and the company reported no share repurchases or on-market sales of treasury stock during the period.
With this completion, China Oral Industry’s enlarged share base reflects the full allotment of the consideration shares, while all other share capital conditions remain unchanged.
Comments